Microbiome Alliance for Disease Prevention (MADP) is a U.S.-based 501(c)(3) public health nonprofit advancing early detection and prevention – breaking down barriers to end chronic disease. MADP is dedicated to advancing public health by expanding access to precision medicine and preventive care across communities nationwide.
Through education, outreach, and advocacy, MADP ensures patients and communities – have access to smarter prevention, earlier detection, and better outcomes.
For patients, navigating the complex clinical field can be overwhelming. Understanding preventive steps is crucial for informed decisions and active participation in one’s own medical care. Knowing what drives disease – and acting early – can save lives.
We are unwavering in our commitment to patients, providers, and communities delivering education and critical supportive resources from guiding smarter preventive screening tests at annual exams to navigating the complex world of tumor biomarkers in cancer care. MADP ensures everyone benefits from the promise of precision healthcare.
Precision, prevention, and early detection are transforming the future of healthcare – redefining how we understand health, treat patients, and combat disease.
Precision Medicine is a fundamental part of preventive healthcare – enabling earlier detection, more accurate diagnoses, and targeted treatments. It takes into account individual differences in patients’ genes, nutrition, environment, lifestyle, and the microbiome.
MADP addresses the leading drivers of noncommunicable chronic diseases (NCDs) – including cancer, heart disease, and diabetes – by advancing precision medicine, the microbiome, and precision nutrition. Translating the life-saving innovations of precision medicine into public health strategies ~ MADP Precision Public Health.
Leveraging smarter preventive screening detects disease at its earliest, most treatable stages.
MADP operates as a COLLABORATIVE ALLIANCE partnering with top medical institutions, clinicians, and researchers from across the country. TOGETHER we break down barriers to bring hope – today, tomorrow, and generations to come.
Chronic diseases are the leading cause of mortality in the U.S. and worldwide, posing a significant public health challenge. It is likely that you or someone you care about has been diagnosed with heart disease, cancer, diabetes, obesity, autoimmune disease, inflammatory bowel disease, or dementia. The majority of chronic diseases progress slowly over multiple years before physical symptoms arise.
Atherosclerosis, for instance, is a gradual process that starts decades prior to developing into heart disease. It can begin as early as the teenage years, progressing slowly through 20’s and 30’s. It is often silent until there is significant artery narrowing or cardiac event later in life.
Various factors including diet, lifestyle choices, genetic predisposition, and underlying medical conditions, influence the rate at which atherosclerosis develops – underscoring the importance of preventive measures and early detection.
Chronic inflammation is often called a “silent driver” of many serious health conditions. It develops slowly and without noticeable symptoms. Unlike acute inflammation – such as redness or swelling that happens with an injury – chronic inflammation can quietly persist in the body for years without being detected.
Over time, this hidden inflammation can damage tissues and organs, playing a central role in the development of noncommunicable diseases (NCDs) such as heart disease, cancer, type 2 diabetes, Alzheimer’s disease, and autoimmune disorders.
Addressing chronic inflammation is a critical part of preventing and managing long-term health conditions.
When battling cancer, every minute matters. MADP is dedicated to supporting cancer patients throughout their journey. We provide comprehensive resources to help patients navigate the complex world of cancer, offering a hopeful approach to understanding the disease and accessing essential care.
MADP collaborates with leading cancer researchers, oncologists, and precision medicine experts to deliver the latest advancements in cancer detection, tumor biomarker testing, and targeted treatments.
We are deeply grateful for their knowledge, expertise, personal cancer survivorship, and commitment to assisting others through MADP’s public health non-profit. Their efforts help us break down barriers and provide critical supportive resources.
MADP Circle of Hope supports individuals recently diagnosed, those undergoing treatment, and cancer survivors. MADP Circle of Hope is here for you Together Fighting Cancer – Every Step of the Way.
Jonathan Peled, MD, Ph.D., Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Justin Sonnenburg, Ph.D., Erica Sonnenburg, Ph.D., and other collaborators, Stanford School of Medicine.
Geoffrey von Maltzahn, Ph.D., Flagship Pioneering, Singularity University Global Summit, A Microbiome Revolution.